The Effect of a Personalized Exercise Program on Muscle Functional Capacity and Quality of Daily Life: A Randomized Pilot Study
Abstract
1. Introduction
- Based on objective measurements;
- Minimizes practitioner-dependent variability;
- Enables inter-individual comparisons;
- Applicable across all age groups;
- Safe for individuals with comorbid conditions.
2. Materials and Methods
2.1. Study Design
- Individuals who had previously attempted conventional exercise methods but had discontinued due to injury or lack of effectiveness;
- Older adults who refused to perform even simple physical activities, including walking, out of fear of injury;
- Individuals with restrictions in daily life activities due to existing knee, hip, or lower back conditions;
- Participants who reported rapid fatigue, increased back pain from routine activities, and general difficulty with movement;
- Adults over the age of 65 whose daily functional capacity had significantly declined, making it difficult for them to perform tasks they previously managed with ease;
- Healthy individuals without diagnosed joint degeneration, but who experienced quick fatigue during routine daily activities;
- Individuals advised by healthcare professionals to increase physical activity due to heart disease, diabetes, or obesity, but who were unable to follow these recommendations because of exacerbated joint-related complaints.
- Individuals undergoing active cancer treatment;
- Those diagnosed with heart failure;
- Individuals who were unable to move independently due to neurological disorders.
- No concurrent medical treatment was administered;
- Participants refrained from any form of sports or physical activity, including recreational walking;
- No physically demanding activities, such as gardening, were permitted.
2.2. Data Analysis Approach
2.3. The Concept of Muscle Functional Capacity
2.3.1. Basic Daily Activity Level (Questionnaire Score Below 40% of the Total Possible Score and Muscle Functional Capacity Between 40% and 60 of the Ideal)
2.3.2. Moderate Daily Activity Level (Questionnaire Score Below 60% of the Total Possible Score and Muscle Functional Capacity Between 60% and 80 of the Ideal)
2.3.3. High-Intensity Daily Activity Level (Questionnaire Score Above 60% of the Total Possible Score and Muscle Functional Capacity of 80% or More)
2.4. Targeted Implementation Strategy
2.5. Questionnaires
2.5.1. Modified Psychological Stress Questionnaire (PSM-9)
2.5.2. Quality of Life in Daily Activities Questionnaire
2.5.3. Physical Stress Questionnaire
2.5.4. Disease Severity Questionnaire
2.6. Exercise Program Methodology
2.7. Implementation and Monitoring
2.7.1. Device Features
2.7.2. Measurement Technique for Muscle Functional Capacity
2.7.3. Data Handling and Software Integration
2.7.4. Adaptation for Athletes
2.7.5. Clinical Utility and Report Generation
2.7.6. Creation of the Exercise Program
2.7.7. Implementation of the Exercise Program
- Negative factors affecting daily life, derived from the four administered questionnaires, were first converted into numerical coefficients.
- The ideal functional capacity each muscle needed to cope with daily life demands was then determined.
- Each muscle group’s current functional capacity was also converted into a corresponding coefficient.
- Disease-specific coefficients were formulated based on the disease severity questionnaire.
- Finally, these diverse coefficients interacted within a mathematical algorithm to precisely tailor the exercise prescription for each individual.
2.7.8. Evaluation of Exercise Program Outcomes
3. Results
3.1. Participant Profile
3.2. Muscle Functional Capacity Outcomes
3.3. Combined Questionnaire Score
3.4. Individual Questionnaire Outcomes
3.4.1. Psychological Stress
3.4.2. Physical Stress
3.4.3. Quality of Life in Daily Activities
3.4.4. Disease Severity
3.5. Gender-Based Comparisons
3.6. Age-Based Comparisons
- Under 40 years;
- 40–64 years;
- 65 years and older.
3.7. Correlation Analyses
3.7.1. Gender-Based Correlation Patterns
3.7.2. Age-Specific Correlations
3.7.3. Interpretation of Correlation Findings
3.8. Summary of Key Findings
3.8.1. Functional Capacity Gains
3.8.2. Questionnaire Improvements
3.8.3. Gender and Age Group Findings
3.8.4. Correlation Analyses
3.8.5. Integration of Results
3.8.6. Additional Notes
- Statistical Significance (p-values):All p-values presented in the tables and the t-test results reflect the reliability of the statistical analyses. For example, a p-value of <0.01 indicates that the result is statistically significant at the 99% confidence level.
- Cohen’s d Interpretation (Effect Size):
- -
- Around 0.2 = small effect;
- -
- Around 0.5 = moderate effect;
- -
- 0.8 and above = large effect;
- -
- 1.2 and above = very large effect.
- Negative Correlation ():Although an inverse relationship between increasing muscle functional capacity and decreasing questionnaire scores is expected, it may not be consistently observed across all individuals due to personal differences in stress profiles, daily life demands, or health status. Therefore, correlations may appear weak or neutral in the general population.
- Statistical Methods: All analyses were based on the study dataset and conducted using the following:
- -
- Paired-sample t-tests for pre–post comparisons;
- -
- Independent-sample t-tests or one-way ANOVA for gender and age group comparisons;
- -
- Pearson correlation coefficients for correlation analyses.
4. Discussion
4.1. Study Limitations
4.1.1. Lack of a Control Group
4.1.2. Absence of Direct Comparison with Traditional Exercise Methods
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- West, L.A.; Cole, S.; Goodkind, D.; He, W. 65+ in the United States: 2010; Current Population Reports, P23-212; U.S. Government Printing Office: Washington, DC, USA, 2014. [Google Scholar]
- Fragala, M.S.; Cadore, E.L.; Dorgo, S.; Izquierdo, M.; Kraemer, W.J.; Peterson, M.D.; Ryan, E.D. Resistance Training for Older Adults: Position Statement From the National Strength and Conditioning Association. J. Strength Cond. Res. 2019, 33, 2019–2052. [Google Scholar] [CrossRef]
- Miller, M.E.; Rejeski, W.J.; Reboussin, B.A.; Ten Have, T.R.; Ettinger, W.H. Physical Activity, Functional Limitations, and Disability in Older Adults. J. Am. Geriatr. Soc. 2000, 48, 1264–1272. [Google Scholar] [CrossRef]
- Evans, W.J.; Campbell, W.W. Sarcopenia and Age-Related Changes in Body Composition and Functional Capacity. J. Nutr. 1993, 123, 465–468. [Google Scholar] [CrossRef]
- Fielding, R.A.; Vellas, B.; Evans, W.J.; Bhasin, S.; Morley, J.E.; Newman, A.B.; Abellan Van Kan, G.; Andrieu, S.; Bauer, J.; Breuille, D.; et al. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. J. Am. Med. Dir. Assoc. 2011, 12, 249–256. [Google Scholar] [CrossRef] [PubMed]
- Lally, F.; Crome, P. Understanding frailty. Postgrad. Med. J. 2007, 83, 16–20. [Google Scholar] [CrossRef] [PubMed]
- Netz, Y.; Yekutieli, Z.; Arnon, M.; Argov, E.; Tchelet, K.; Benmoha, E.; Jacobs, J.M. Personalized Exercise Programs Based upon Remote Assessment of Motor Fitness: A Pilot Study among Healthy People Aged 65 Years and Older. Gerontology 2022, 68, 465–479. [Google Scholar] [CrossRef] [PubMed]
- Puterman, E.; Lin, J.; Blackburn, E.; O’Donovan, A.; Adler, N.; Epel, E. The Power of Exercise: Buffering the Effect of Chronic Stress on Telomere Length. PLoS ONE 2010, 5, e10837. [Google Scholar] [CrossRef]
- Mannion, A.F.; O’Riordan, D.; Dvorak, J.; Masharawi, Y. The relationship between psychological factors and performance on the Biering-Sørensen back muscle endurance test. Spine J. 2011, 11, 849–857. [Google Scholar] [CrossRef]
- Brach, M.; De Bruin, E.D.; Levin, O.; Hinrichs, T.; Zijlstra, W.; Netz, Y. Evidence-based yet still challenging! Research on physical activity in old age. Eur. Rev. Aging Phys. Act. 2023, 20, 7. [Google Scholar] [CrossRef]
- Meredith, C.N.; Zackin, M.J.; Frontera, W.R.; Evans, W.J. Body composition and aerobic capacity in young and middle-aged endurance-trained men. Med. Sci. Sport. Exerc. 1987, 19, 557–563. [Google Scholar] [CrossRef]
- Epel, E.S.; Blackburn, E.H.; Lin, J.; Dhabhar, F.S.; Adler, N.E.; Morrow, J.D.; Cawthon, R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 2004, 101, 17312–17315. [Google Scholar] [CrossRef] [PubMed]
- Rodenberg, R.E.; Bowman, E.; Ravindran, R. Overuse Injuries. Prim. Care Clin. Off. Pract. 2013, 40, 453–473. [Google Scholar] [CrossRef]
- Von Korff, M.R. Health Care for Chronic Pain: Overuse, Underuse, and Treatment Needs Commentary on Chronic Pain and Health Services Utilization—Is There Overuse of Diagnostic Tests and Inequalities in Nonpharmacologic Methods Utilization? Med. Care 2013, 51, 857–858. [Google Scholar] [CrossRef] [PubMed]
- Sperling, L. Evaluation of upper extremity function in 70-year-old men and women. Scand. J. Rehabil. Med. 1980, 12, 139–144. [Google Scholar] [PubMed]
- Lemyre, L.; Tessier, R. Measuring psychological stress. Concept, model, and measurement instrument in primary care research. Can. Fam. Physician Med. Fam. Can. 2003, 49, 1159–1160, 1166–1168. [Google Scholar]
- The Whoqol Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol. Med. 1998, 28, 551–558. [Google Scholar] [CrossRef] [PubMed]
- Janssen, I.; Shepard, D.S.; Katzmarzyk, P.T.; Roubenoff, R. The Healthcare Costs of Sarcopenia in the United States. J. Am. Geriatr. Soc. 2004, 52, 80–85. [Google Scholar] [CrossRef]
- Hughes, S.L.; Leith, K.H.; Marquez, D.X.; Moni, G.; Nguyen, H.Q.; Desai, P.; Jones, D.L. Physical Activity and Older Adults: Expert Consensus for a New Research Agenda. Gerontologist 2011, 51, 822–832. [Google Scholar] [CrossRef]
- Gracey, E.; Burssens, A.; Cambré, I.; Schett, G.; Lories, R.; McInnes, I.B.; Asahara, H.; Elewaut, D. Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis. Nat. Rev. Rheumatol. 2020, 16, 193–207. [Google Scholar] [CrossRef]
- Liu, S.; Nong, W.; Ji, L.; Zhuge, X.; Wei, H.; Luo, M.; Zhou, L.; Chen, S.; Zhang, S.; Lei, X.; et al. The regulatory feedback of inflammatory signaling and telomere/telomerase complex dysfunction in chronic inflammatory diseases. Exp. Gerontol. 2023, 174, 112132. [Google Scholar] [CrossRef]
- Allen, J.; Morelli, V. Aging and Exercise. Clin. Geriatr. Med. 2011, 27, 661–671. [Google Scholar] [CrossRef] [PubMed]
- Chen, N.; He, X.; Feng, Y.; Ainsworth, B.E.; Liu, Y. Effects of resistance training in healthy older people with sarcopenia: A systematic review and meta-analysis of randomized controlled trials. Eur. Rev. Aging Phys. Act. 2021, 18, 23. [Google Scholar] [CrossRef] [PubMed]
- Barua, D.S.; Roy, V.; Ahmed, J.; Pandey, D.; Shah, V.; Ashraf, S.; Karim, M. Medial Knee Joint Space in Relation to Joint Function and Early Knee Pain in 20–45-Year Adults: A Cross Sectional Study. Indian J. Orthop. 2023, 57, 1640–1645. [Google Scholar] [CrossRef] [PubMed]
- Briggs, A.M.; Cross, M.J.; Hoy, D.G.; Sànchez-Riera, L.; Blyth, F.M.; Woolf, A.D.; March, L. Musculoskeletal Health Conditions Represent a Global Threat to Healthy Aging: A Report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist 2016, 56, S243–S255. [Google Scholar] [CrossRef]
- Marini, M.; Sarchielli, E.; Brogi, L.; Lazzeri, R.; Salerno, R.; Sgambati, E.; Monaci, M. Role of adapted physical activity to prevent the adverse effects of the sarcopenia. A pilot study. Ital. J. Anat. Embryol. Arch. Ital. Anat. Embriol. 2008, 113, 217–225. [Google Scholar]
- Sibille, K.T.; Langaee, T.; Burkley, B.; Gong, Y.; Glover, T.L.; King, C.; Riley, J.L.; Leeuwenburgh, C.; Staud, R.; Bradley, L.A.; et al. Chronic Pain, Perceived Stress, and Cellular Aging: An Exploratory Study. Mol. Pain 2012, 8, 1744–8069–8–12. [Google Scholar] [CrossRef]
- Young, H.M.L.; Henson, J.; Dempsey, P.C.; Willis, S.A.; Billany, R.E.; Curtis, F.; Gray, L.; Greenwood, S.; Herring, L.Y.; Highton, P.; et al. Physical activity and sedentary behaviour interventions for people living with both frailty and multiple long-term conditions and their informal carers: A scoping review and stakeholder consultation. Age Ageing 2024, 53, afae255. [Google Scholar] [CrossRef]
- Hurst, C.; Sayer, A.A. Improving muscle strength and physical function in older people living with sarcopenia and physical frailty: Not all exercise is created equal. J. R. Coll. Physicians Edinb. 2022, 52, 166–171. [Google Scholar] [CrossRef]
- Siscovick, D.S.; LaPorte, R.E.; Newman, J.M. The disease-specific benefits and risks of physical activity and exercise. Public Health Rep. 1985, 100, 180–188. [Google Scholar]
- Hurst, C.; Dismore, L.; Granic, A.; Tullo, E.; Noble, J.M.; Hillman, S.J.; Witham, M.D.; Sayer, A.A.; Dodds, R.M.; Robinson, S.M. Attitudes and barriers to resistance exercise training for older adults living with multiple long-term conditions, frailty, and a recent deterioration in health: Qualitative findings from the Lifestyle in Later Life—Older People’s Medicine (LiLL-OPM) study. BMC Geriatr. 2023, 23, 772. [Google Scholar] [CrossRef]
Device Name | Targeted Muscle Group |
---|---|
Leg Press | Hip and knee muscles |
Chest Press | Chest and anterior shoulder muscles |
Leg Extension | Anterior thigh muscles |
Rowing | Back and neck muscles |
Triceps | Posterior arm muscles |
Back Trainer | Lumbar and spinal muscles |
Abdominals | Abdominal muscles |
Lat Pulldown | Shoulder and arm muscles |
Leg Curl | Posterior thigh muscles |
Fly | Anterior chest muscles |
Adduction | Hip and leg adductor muscles |
Abduction | Hip and leg abductor muscles |
Shoulder Press | Shoulder and arm muscles |
Muscle Groups | 2 December 2021 Max. Functional Capacity (%) | 26 April 2022 Max. Functional Capacity (%) | Development (% Increase) |
---|---|---|---|
Leg Press | 85.00 | 100.00 | 15.00 |
Chest Press | 35.00 | 58.33 | 23.33 |
Leg Extension | 66.00 | 75.00 | 9.00 |
Rowing | 53.00 | 90.00 | 37.00 |
Triceps | 52.00 | 73.00 | 21.00 |
BackTrainer | 71.25 | 100.00 | 28.75 |
Abdomen | 53.75 | 100.00 | 46.25 |
Pull Down | 57.50 | 75.00 | 17.50 |
Leg Curl | 78.57 | 100.00 | 21.43 |
Fly | 27.69 | 32.31 | 4.62 |
Adduction | 66.67 | 80.00 | 13.33 |
Abduction | 91.67 | 100.00 | 8.33 |
Shoulder | 56.67 | 63.33 | 6.66 |
Total Average | 61.14 | 80.54 | 19.40 |
Muscle Group | Set 1 | Reps 1 | Resistance 1 (kg) | Set 2 | Reps 2 | Resistance 2 (kg) |
---|---|---|---|---|---|---|
Leg Press | 2 | 16 | 25.50 | 2 | 16 | 30.60 |
Chest Press | 2 | 22 | 6.30 | 2 | 22 | 7.56 |
Leg Extension | 2 | 28 | 9.90 | 2 | 28 | 11.88 |
Rowing | 2 | 27 | 7.95 | 2 | 27 | 9.54 |
Triceps | 2 | 27 | 7.80 | 2 | 27 | 9.36 |
Back Trainer | 3 | 23 | 8.55 | 3 | 23 | 10.26 |
Abdomen | 3 | 22 | 6.45 | 3 | 22 | 7.74 |
Pull Down | 3 | 22 | 6.90 | 3 | 22 | 8.28 |
Leg Curl | 3 | 26 | 8.25 | 3 | 26 | 9.90 |
Fly | 3 | 26 | 2.70 | 3 | 26 | 3.24 |
Adduction | 3 | 29 | 6.00 | 3 | 29 | 7.20 |
Abduction | 3 | 30 | 8.25 | 3 | 30 | 9.90 |
Shoulder | 3 | 29 | 5.10 | 3 | 29 | 6.12 |
Muscle Group | Set 1 | Reps 1 | Resistance 1 (kg) | Set 2 | Reps 2 | Resistance 2 (kg) |
---|---|---|---|---|---|---|
Leg Press | 2 | 17 | 30.00 | 2 | 17 | 36.00 |
Chest Press | 2 | 23 | 10.50 | 2 | 23 | 12.60 |
Leg Extension | 2 | 28 | 11.25 | 2 | 28 | 13.50 |
Rowing | 2 | 29 | 13.50 | 2 | 29 | 16.20 |
Triceps | 2 | 28 | 10.95 | 2 | 28 | 13.14 |
Back Trainer | 3 | 24 | 12.00 | 3 | 24 | 14.40 |
Abdomen | 3 | 24 | 12.00 | 3 | 24 | 14.40 |
Pull Down | 3 | 23 | 9.00 | 3 | 23 | 10.80 |
Leg Curl | 3 | 26 | 10.50 | 3 | 26 | 12.60 |
Fly | 3 | 26 | 3.15 | 3 | 26 | 3.78 |
Adduction | 3 | 30 | 7.20 | 3 | 30 | 8.64 |
Abduction | 3 | 30 | 9.00 | 3 | 30 | 10.80 |
Shoulder | 3 | 29 | 5.70 | 3 | 29 | 6.84 |
Disease | Participants (n, %) |
---|---|
Lumbar Disc Disease | 104 (61.53) |
Surgery for Lumbar Disc | 11 (6.50) |
Cervical Disc Disease | 37 (21.99) |
Surgery for Cervical Disc Disease | 2 (1.18) |
Shoulder Problems | 34 (20.11) |
Hip Problems | 26 (15.38) |
Knee Problems | 49 (28.99) |
Hypertension | 23 (13.60) |
Diabetes Mellitus | 21 (12.42) |
Obesity | 14 (8.28) |
Mild Neuropathy | 16 (9.46) |
Hypothyroidism | 11 (6.50) |
COVID-19 | 2 (1.18) |
Cancer (older than two years) | 10 (5.95) |
Test Period | Mean (%) | Standard Deviation (±SD) | t(df), p | Cohen’s d |
---|---|---|---|---|
Pre-Test | 57.06 | ±14.13 | t(168) = −30.65, p < 0.01 | −2.35 |
Post-Test | 75.17 | ±12.19 | Very large effect size |
Group | Pre Mean ± SD | Post Mean ± SD | (Mean ± SD) | t(df) | p | Cohen’s d |
---|---|---|---|---|---|---|
Women < 40 | 59.31 ± 10.16 | 76.62 ± 8.50 | 17.31 ± 6.85 | 11.30 (19) | <0.0001 | 2.35 |
Women 40–64 | 56.12 ± 13.17 | 73.84 ± 11.98 | 17.72 ± 8.69 | 16.18 (55) | <0.0001 | 2.04 |
Women 65+ | 53.89 ± 14.10 | 70.67 ± 12.12 | 16.78 ± 9.11 | 11.65 (46) | <0.0001 | 1.84 |
Men < 40 | 63.25 ± 9.88 | 81.75 ± 10.12 | 18.50 ± 7.12 | 7.80 (8) | <0.0001 | 2.60 |
Men 40–64 | 56.78 ± 13.45 | 74.22 ± 12.35 | 17.44 ± 7.65 | 11.40 (14) | <0.0001 | 2.28 |
Men 65+ | 55.50 ± 12.50 | 72.80 ± 11.00 | 17.30 ± 7.00 | 11.62 (21) | <0.0001 | 2.47 |
Test Period | Mean (Total Score) | SD (±) | t(df), p | Cohen’s d |
---|---|---|---|---|
Pre-Test | 142.08 | 23.37 | , | 1.42 |
Post-Test | 109.57 | 18.01 | Very large effect size |
Group | n | Pre Mean ± SD | Post Mean ± SD | (Mean ± SD) | t(df), p | 95% CI, d |
---|---|---|---|---|---|---|
Female < 40 | 20 | 149.08 ± 11.48 | 127.31 ± 10.68 | 21.77 ± 8.96 | 10.87 (19), | [17.58, 25.96], d = 2.43 |
Female 40–64 | 56 | 142.80 ± 24.00 | 107.10 ± 19.00 | 35.70 ± 24.50 | 11.55 (55), | [29.53, 41.87], d = 1.46 |
Female | 47 | 144.50 ± 23.50 | 108.20 ± 18.50 | 36.30 ± 22.00 | 9.63 (46), | [29.14, 44.64], d = 1.65 |
Male < 40 | 9 | 151.33 ± 10.19 | 130.00 ± 10.10 | 21.33 ± 7.98 | 8.01 (8), | [16.99, 27.47], d = 2.67 |
Male 40–64 | 15 | 144.20 ± 23.82 | 108.76 ± 17.43 | 35.44 ± 25.09 | 7.06 (14), | [25.08, 45.80], d = 1.41 |
Male | 22 | 138.50 ± 26.50 | 105.10 ± 19.00 | 33.40 ± 26.00 | 6.03 (21), | [20.40, 46.40], d = 1.29 |
Test Period | Mean ± SD | t(df), p | Cohen’s d |
---|---|---|---|
Pre-Test | 31.12 ± 9.31 | , | 1.25 |
Post-Test | 18.79 ± 6.40 | Large effect size |
Test Period | Mean ± SD | t(df), p | Cohen’s d |
---|---|---|---|
Pre-Test | 48.27 ± 8.62 | , | 0.56 |
Post-Test | 43.94 ± 6.41 | Moderate effect size |
Test Period | Mean ± SD | t(df), p | Cohen’s d |
---|---|---|---|
Pre-Test | 51.54 ± 12.30 | , | 0.75 |
Post-Test | 40.75 ± 9.49 | Moderate to large effect size |
Test Period | Mean ± SD | t(df), p | Cohen’s d |
---|---|---|---|
Pre-Test | 11.30 ± 7.14 | , | 0.89 |
Post-Test | 6.27 ± 4.07 | Large effect size |
Group | Mean Difference ± SD | t(df), p | Cohen’s d |
---|---|---|---|
Male | 32.42 ± 19.70 | , | ≈0 |
Female | 32.54 ± 24.19 | Negligible effect |
Group | Mean Difference ± SD | t(df), p | Cohen’s d |
---|---|---|---|
Male | 15.75 ± 7.12 | , | ≈0.44 |
Female | 19.02 ± 7.78 | Small to moderate effect |
Questionnaire | Female Mean | Male Mean | t-Value | p-Value | Significance |
---|---|---|---|---|---|
Psychological Stress | 12.89 | 10.80 | −1.24 | 0.22 | Not significant |
Physical Stress | 4.63 | 3.54 | −0.80 | 0.42 | Not significant |
Quality of Life in Activities | 10.15 | 12.50 | 0.95 | 0.35 | Not significant |
Disease Severity | 4.87 | 5.43 | 0.58 | 0.56 | Not significant |
Age Group | Mean Difference (%) | Standard Deviation |
---|---|---|
<40 years | ∼15.52 | ∼7.09 |
40–64 years | ∼18.32 | ∼7.32 |
65+ years | ∼19.17 | ∼8.23 |
Age Group | Mean Difference ± SD (Total Score) |
---|---|
<40 years | 36.60 ± 25.73 |
40–64 years | 31.87 ± 25.22 |
65+ years | 31.40 ± 19.14 |
Age Group | Physical Stress Mean Difference |
---|---|
<40 years | 0.93 |
40–64 years | 5.35 |
65+ years | 4.71 |
Variables | Correlation (r) | p-Value |
---|---|---|
Muscle Functional Capacity Increase ∼ Total Questionnaire Score Difference | 0.02 | 0.79 |
Muscle Functional Capacity Increase ∼ Psychological Stress Difference | −0.02 | 0.82 |
Muscle Functional Capacity Increase ∼ Physical Stress Difference | 0.02 | 0.83 |
Muscle Functional Capacity Increase ∼ Quality of Life Difference | 0.06 | 0.47 |
Muscle Functional Capacity Increase ∼ Disease Severity Difference | −0.05 | 0.54 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ercan, S.; Yalçınol, T.; Öngel, Ö. The Effect of a Personalized Exercise Program on Muscle Functional Capacity and Quality of Daily Life: A Randomized Pilot Study. Int. J. Environ. Res. Public Health 2025, 22, 1344. https://doi.org/10.3390/ijerph22091344
Ercan S, Yalçınol T, Öngel Ö. The Effect of a Personalized Exercise Program on Muscle Functional Capacity and Quality of Daily Life: A Randomized Pilot Study. International Journal of Environmental Research and Public Health. 2025; 22(9):1344. https://doi.org/10.3390/ijerph22091344
Chicago/Turabian StyleErcan, Semra, Türkü Yalçınol, and Özge Öngel. 2025. "The Effect of a Personalized Exercise Program on Muscle Functional Capacity and Quality of Daily Life: A Randomized Pilot Study" International Journal of Environmental Research and Public Health 22, no. 9: 1344. https://doi.org/10.3390/ijerph22091344
APA StyleErcan, S., Yalçınol, T., & Öngel, Ö. (2025). The Effect of a Personalized Exercise Program on Muscle Functional Capacity and Quality of Daily Life: A Randomized Pilot Study. International Journal of Environmental Research and Public Health, 22(9), 1344. https://doi.org/10.3390/ijerph22091344